WOEST ( What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing)

NCT00769938 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

573

Enrollment

OTHER

Sponsor class

Conditions

Anticoagulants
Platelet Aggregation Inhibitors
Stents
Atrial Fibrillation

Interventions

DEVICE: PCI (percutaneous coronary intervention)

Sponsor

R&D Cardiologie